Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01162343 · ClinicalTrials.gov registry record
Delirium in the Emergency Department: Novel Screening
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 498
- Enrollment target
NCT01162343: Completed study, sponsored by Vanderbilt University Medical Center.
NCT01162343 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 498 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01162343 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 498 participants
- Enrollment target
Study Summary
Delirium is an acute confusional state characterized by altered or fluctuating mental status, inattention, and either disorganized thinking or an altered level of consciousness. This form of organ dysfunction occurs in up to 10% of older emergency department (ED) patients and is associated with worsening mortality, prolonged hospital length of stay, higher health care costs, and accelerated functional and cognitive decline. Despite the negative consequences of delirium, the majority of cases are unrecognized by emergency physicians because it is not routinely screened for. In an effort to facilitate delirium screening, the investigators sought to validate three brief delirium assessments in the ED setting.
Primary Outcome
Delirium was diagnosed by a consultation-liaison psychiatrist assessment using Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria. The psychiatrists performed a battery of bedside cognitive tests, including (but not limited to) Clock Drawing Test, Luria hand sequencing task, and tests for verbal fluency. A focused neurological examination (i.e., screening for paraphasic errors, tremors, tone, asterixis, frontal release signs etc.,) and evalu
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 498 participants |
| Start Date | 2009-07 |
| Est. Completion | 2012-02 |
What the finished NCT01162343 record still lists
NCT01162343 is an observational study that tracks outcomes without assigning an intervention. The registered 498 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01162343 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01162343 about?
NCT01162343 is a clinical study titled "Delirium in the Emergency Department: Novel Screening". Delirium is an acute confusional state characterized by altered or fluctuating mental status, inattention, and either disorganized thinking or an altered level of consciousness. This form of organ dysfunction occurs in up to 10% of older emergency department (ED) patients and is associated with wors...
What is the current status of trial NCT01162343?
This trial is currently completed. The enrollment target is 498 participants. The study started on 2009-07. Estimated completion is 2012-02.
Who is sponsoring clinical trial NCT01162343?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04137900 · 499 participants · Phase 1
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
- NCT06733480 · 499 participants · NA
Innovating Physical Therapy: A Pilot Study on Band Connect's Impact on Compliance, Satisfaction, and Revenue
- NCT03175224 · 497 participants · Phase 2
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- NCT05301816 · 497 participants · NA
PDN Post Market, Multicenter, Prospective, Global Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia